Position Statements
Stem Cell Research
Medicare Coverage of DXA Bone Density Testing in Men
Endocrine-Disrupting Chemicals
Bioequivalence of Sodium Levothyroxine
Steroid Abuse
Biomedical Research Funding
Access to Affordable and Adequate Diabetes Supplies
Monitoring and Reporting Drug Shortages
Bioidentical Hormones
Pay-for-Performance
Clinical Trial Registries
Society Recommends Against Altering Blood Glucose Control Goals
The Endocrine Society Statement on the Use of A1C for Diabetes DiagnosisLantus (Insulin Glargine) Statement for Patients
Guiding Principles for Health Reform
The Endocrine Society Statement to Providers on the Report Published in the New England Journal of Medicine on NICE-SUGAR
The Endocrine Society Statement on ACCORD Trial
Joint Statement on Levothyroxine and Thyroxine
Statement to Providers on the Report Published in the New England Journal of Medicine on Avandia
Summary of Medicare Reform Legislation
Position Statements Under Review
No position statements are currently open for review.
